Gilgamesh Pharmaceuticals Patents – Insights & Stats (Updated 2023)

Gilgamesh Pharmaceuticals has a total of 56 patents globally, out of which 3 have been granted. Of these 56 patents, more than 91% patents are active. United States of America is where Gilgamesh Pharmaceuticals has filed the maximum number of patents, followed by Canada and New Zealand. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Gilgamesh Pharmaceuticals.

Gilgamesh Pharmaceuticals was founded in the year 2019. The Company provides medicines for psychedelic, novel psychotropic drugs, depression, anxiety and stress-related disorders.

Do read about some of the most popular patents of Gilgamesh Pharmaceuticals which have been covered by us in this article and also you can find Gilgamesh Pharmaceuticals patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Gilgamesh Pharmaceuticals patent portfolio.

How many patents does the founder and the CEO of Gilgamesh Pharmaceuticals have?

The founder Andrew Kruegel has 1 patent and CEO Jonathan Sporn has 14 patents.

How many patents does Gilgamesh Pharmaceuticals have?

Gilgamesh Pharmaceuticals has a total of 56 patents globally. These patents belong to 12 unique patent families. Out of 56 patents, 51 patents are active.

How Many Patents did Gilgamesh Pharmaceuticals File Every Year?

Gilgamesh Pharmaceuticals Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantGilgamesh Pharmaceuticals Applications FiledGilgamesh Pharmaceuticals Patents Granted
202381
2022172
202123
20208

How many Gilgamesh Pharmaceuticals patents are Alive/Dead?

Gilgamesh Pharmaceuticals Patent Portfolio

 How Many Patents did Gilgamesh Pharmaceuticals File in Different Countries?

Gilgamesh Pharmaceuticals Worldwide Patent Filing

Countries in which Gilgamesh Pharmaceuticals Filed Patents

CountryPatents
United States Of America7
Canada4
New Zealand4
South Africa4
Israel4
Australia4
Japan4
Mexico3
Europe3
Singapore3
India3
Brazil2

Where are Research Centres of Gilgamesh Pharmaceuticals Patents Located?

R&D Centers of Gilgamesh Pharmaceuticals

What Percentage of Gilgamesh Pharmaceuticals US Patent Applications were Granted?

Gilgamesh Pharmaceuticals (Excluding its subsidiaries) has filed 2 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 2 have been granted leading to a grant rate of 100.0%.

Below are the key stats of Gilgamesh Pharmaceuticals patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Gilgamesh Pharmaceuticals?

Law FirmTotal ApplicationsSuccess Rate
Scully Scott Murphy & Presser2100.00%

What are Gilgamesh Pharmaceuticals key innovation segments?

What Technologies are Covered by Gilgamesh Pharmaceuticals?

The chart below distributes patents filed by Gilgamesh Pharmaceuticals in different countries on the basis of the technology protected in patents. It also represents the markets where Gilgamesh Pharmaceuticals thinks it’s important to protect particular technology inventions.

R&D Focus: How has Gilgamesh Pharmaceuticals search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Gilgamesh Pharmaceuticals?

Related Articles

Xiamen Easo Patents – Insights & Stats (Updated 2024)

Xiamen Easo has a total of 681 patents globally, out of which 536 have been granted. Of these 681 patents, more than 59% patents are active. China is where Xiamen Easo has filed the maximum number of patents, followed by United States of America and Europe (EPO). Parallelly, China seems

Read More »

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.